Effectiveness of a smoking cessation algorithm integrated into HIV primary care
纳入艾滋病毒初级保健的戒烟算法的有效性
基本信息
- 批准号:10163034
- 负责人:
- 金额:$ 9.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAbstinenceAddressAdolescent and Young AdultAffectAfrican AmericanAgeAlabamaAlgorithmic SoftwareAlgorithmsAppointmentAttitudeBeliefBiochemicalBostonCannabisCaringCessation of lifeCharacteristicsChronic DiseaseCigaretteClimateClinicClinic VisitsClinicalClinical TrialsComputerized Medical RecordControl GroupsDiabetes MellitusDimensionsDisease ManagementEffectivenessEffectiveness of InterventionsEnsureEvaluationFocus GroupsFrequenciesFundingFutureGeneral PopulationGoalsHIVHealthHourHybridsHypertensionIndividualInfrastructureInstitutesInsuranceInterventionInterviewKnowledgeLawsLegalLegal StatusLifeLife ExpectancyLungMarijuanaMassachusettsMedicalMedical MarijuanaMental HealthMental disordersMethadoneMethodsModalityMorbidity - disease rateMotivationNeighborhood Health CenterNicotine DependenceOutcomeParentsParticipantPatientsPatternPerceptionPharmaceutical PreparationsPharmacologyPharmacotherapyPhysiciansPhysiologicalPilot ProjectsPopulationPositioning AttributePrevalencePrimary Health CareProviderPsychosocial FactorRandomizedRecommendationReportingResearchResourcesRiskRisk FactorsSelf EfficacySelf MedicationSiteSmokeSmokerSmokingSmoking Cessation InterventionSmoking StatusStatutes and LawsSystemTechnologyTestingTimeTobaccoTobacco Use CessationTobacco Use DisorderTobacco useTrainingUniversitiesVisitWashingtonWomanWorkagedarmbasecare providerscigarette smokeclimate changeclinical careclinical practiceclinical research sitecomorbiditycomparative efficacycostcost effectivenesscost estimatedemographicsdesigneffectiveness evaluationeffectiveness trialexperiencefollow-upindividual patientinterestintervention costmarijuana legalizationmarijuana usemarijuana vapingmen who have sex with menmodifiable riskmortalitynovelparent projectpleasurepost interventionprimary outcomeprogramsreduce tobacco usesecondary analysissmoking cessationstandard of caresuccesssuccessful interventiontobacco cessation interventiontobacco productstooltreatment armtreatment as usualtreatment comparisontreatment groupuptakevapingyoung adult
项目摘要
Project Summary/Abstract
People living with HIV (PLWH) aged 18-24 disproportionately use tobacco with half of those
individuals also using some form of cannabis. While the exact amount of PLWH aged 18-24
who co-use tobacco and cannabis is unknown, the amount of co-users is only expected to
increase due to changing cannabis legislation and increasing availability and popularity of
vaping both tobacco and cannabis products. Unfortunately, these changes have the potential to
have a profound impact on the morbidity of PLWH aged 18-24. Tobacco alone is known to be
detrimental to lung health and while cannabis has been shown to have similar physiologic
effects on lung health as tobacco, the combined effects of tobacco and cannabis and
specifically for those who are vaping are less well studied among PLWH. Furthermore, among
individuals who are attempting tobacco cessation, cannabis use has been shown to lead to
difficulties with tobacco cessation and even tobacco re-initiation. Use of a decisional algorithm
tool that aids providers in prescribing pharmacotherapy for tobacco cessation during routine
clinical care is one promising strategy for tobacco cessation. While the parent study of this
supplement seeks to evaluate the effectiveness of this decisional tool in tobacco cessation
among PLWH engaged in care at three clinical sites (University of Washington, University of
Alabama at Birmingham, Fenway Community Health Center), the purpose of this supplemental
proposal is to understand how tobacco-cannabis co-use affects tobacco cessation in PLWH
aged 18-24 who were randomized to receive the decisional algorithm tool. Focus groups and
in-depth interviews will be used to examine patient and provider attitudes about tobacco
cessation modalities and cannabis’ effects on cessation. Additionally, a secondary analysis
from specific aim 1 of the parent study will be performed on PLWH aged 18-24. Primary
outcomes will include an evaluation of the feasibility and acceptability of the algorithm tool and a
comparison of the point prevalence abstinence and cannabis frequency at 6 months between
tobacco and cannabis co-users and tobacco-only users. Findings from this study will help
inform the next iteration of the algorithm by providing specific information on PLWH aged 18-24
who co-use tobacco and cannabis.
项目概要/摘要
18-24 岁的艾滋病毒感染者 (PLWH) 吸烟比例过高,其中一半人
18-24 岁的感染者的确切数量也使用某种形式的大麻。
谁同时使用烟草和大麻尚不清楚,预计共同使用者的数量仅
由于大麻立法的变化以及大麻的供应和普及而增加
不幸的是,这些变化有可能会影响烟草和大麻产品。
据了解,仅烟草就对 18-24 岁艾滋病感染者的发病率产生深远影响。
疲劳对肺部健康的影响,而大麻已被证明具有类似的生理作用
烟草对肺部综合健康的影响、烟草和大麻的影响以及
专门针对那些吸电子烟的人群,在 PLWH 中的研究还较少。
尝试戒烟的个人,吸食大麻已被证明会导致
戒烟甚至重新开始吸烟的困难 使用决策算法。
帮助提供者在日常戒烟药物治疗中使用的工具
临床护理是一种有前途的戒烟策略,而这项研究的母公司。
补充剂旨在评估这一决策工具在戒烟方面的有效性
在三个临床中心(华盛顿大学、华盛顿大学)从事护理工作的感染者中
阿拉巴马州伯明翰芬威社区健康中心),本补充的目的
提案旨在了解烟草与大麻的共同使用如何影响 PLWH 的戒烟
18-24 岁的人被随机分配接受决策算法工具和焦点小组。
将通过深入访谈来调查患者和提供者对烟草的态度
戒烟方式和大麻对戒烟的影响。
根据具体目标 1,家长研究将针对 18-24 岁的感染者进行。
结果将包括对算法工具的可行性和可接受性的评估以及
6 个月时戒断率和大麻频率的比较
这项研究的结果将有助于烟草和大麻的共同使用者以及仅吸烟者。
通过提供 18-24 岁 PLWH 的具体信息,为算法的下一次迭代提供信息
谁同时使用烟草和大麻。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heidi M. Crane其他文献
Heidi M. Crane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heidi M. Crane', 18)}}的其他基金
Understanding Health Inequities at the Intersection of the HIV and substance use epidemics across racial/ethnic and other underserved populations
了解不同种族/族裔和其他服务不足人群中艾滋病毒和药物滥用流行病交汇处的健康不平等
- 批准号:
10738418 - 财政年份:2023
- 资助金额:
$ 9.71万 - 项目类别:
Alcohol Research Consortium in HIV: Epidemiology Research Arm
艾滋病毒酒精研究联盟:流行病学研究部门
- 批准号:
10304374 - 财政年份:2021
- 资助金额:
$ 9.71万 - 项目类别:
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)
阿片类药物使用研究和治疗计划的农村合并症和艾滋病毒后果(农村队列)
- 批准号:
9762537 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)
阿片类药物使用研究和治疗计划的农村合并症和艾滋病毒后果(农村队列)
- 批准号:
10369630 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)
阿片类药物使用研究和治疗计划的农村合并症和艾滋病毒后果(农村队列)
- 批准号:
9882992 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
现代抗逆转录病毒疗法相关毒性、耐受性和合并症的药物基因组学和系统药理学方法
- 批准号:
10668985 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)
阿片类药物使用研究和治疗计划的农村合并症和艾滋病毒后果(农村队列)
- 批准号:
10600982 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
现代抗逆转录病毒疗法相关毒性、耐受性和合并症的药物基因组学和系统药理学方法
- 批准号:
10198979 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
Implementation and Evaluation of psPRO: Person-specific Patient-Reported Outcome Assessments for Patients in HIV Care living with Multiple Chronic Conditions
psPRO 的实施和评估:对患有多种慢性病的 HIV 护理患者进行个体化患者报告的结果评估
- 批准号:
10002227 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
Implementation and Evaluation of psPRO: Person-specific Patient-Reported Outcome Assessments for Patients in HIV Care living with Multiple Chronic Conditions
psPRO 的实施和评估:对患有多种慢性病的 HIV 护理患者进行个体化患者报告的结果评估
- 批准号:
9789484 - 财政年份:2019
- 资助金额:
$ 9.71万 - 项目类别:
相似国自然基金
趋化因子CXCL14在胚胎植入中的作用及机制研究
- 批准号:30670785
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
人工泵式括约肌对去肛门括约肌犬节制排便的实验研究
- 批准号:39670706
- 批准年份:1996
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
Evaluating Smoking Cessation and Harm Reduction Approaches among People Living with HIV/AIDS in South Africa
评估南非艾滋病毒/艾滋病感染者的戒烟和减少危害方法
- 批准号:
10537967 - 财政年份:2022
- 资助金额:
$ 9.71万 - 项目类别:
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
使用多阶段优化策略 (MOST) 为 HIV 临床护理中的吸烟者优化具有成本效益、可持续且可扩展的戒烟方案
- 批准号:
10548592 - 财政年份:2022
- 资助金额:
$ 9.71万 - 项目类别:
Human/Animal Brain Chimera in drugs of abuse and HIV
滥用药物和艾滋病毒中的人/动物脑嵌合体
- 批准号:
10543385 - 财政年份:2022
- 资助金额:
$ 9.71万 - 项目类别:
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
博茨瓦纳戒烟强化试验(BSMART)
- 批准号:
10541071 - 财政年份:2022
- 资助金额:
$ 9.71万 - 项目类别:
Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT)
通过为柬埔寨艾滋病毒/艾滋病感染者提供交互式定制信息来结束烟草使用 (EndIT)
- 批准号:
10490323 - 财政年份:2021
- 资助金额:
$ 9.71万 - 项目类别: